Srivichaivejvivat PCLBKK:VIH-R 81 EV-to-EBITDA is 5.13 as of Jul. 05, 2026, which is 41% below its 10-year median of 8.75. GuruFocus rates BKK:VIH-R with a GF Score™ of 81/100 and a GF Value™ of ฿8.92. The stock has 4 warning signs investors should review. Among 505 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 85.54% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Srivichaivejvivat PCL's enterprise value is ฿3,798 Mil.
Srivichaivejvivat PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿740 Mil. Therefore, Srivichaivejvivat PCL's EV-to-EBITDA for today is 5.13.
The historical rank and industry rank for Srivichaivejvivat PCL's EV-to-EBITDA or its related term are showing as below:
BKK:VIH-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.97 Med: 8.75 Max: 25.77
Current: 5.13
During the past 13 years, the highest EV-to-EBITDA of Srivichaivejvivat PCL was 25.77. The lowest was 1.97. And the median was 8.75.
BKK:VIH-R's EV-to-EBITDA is ranked better than 85.54% of 505
companies
in the Healthcare Providers & Services industry
Industry Median: 10.98
vs BKK:VIH-R: 5.13
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Srivichaivejvivat PCL's PE Ratio (TTM) for today is calculated as:
Srivichaivejvivat PCL's share price for today is ฿8.94941.
Srivichaivejvivat PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.715.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Srivichaivejvivat PCL EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Srivichaivejvivat PCL's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIH-R vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's EV-to-EBITDA falls into.
Srivichaivejvivat PCL's current Enterprise Value is ฿3,798 Mil.
Srivichaivejvivat PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿740 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a EV-to-EBITDA of 5.13 as of Jul. 05, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Srivichaivejvivat PCL. This is 41% below median its historical median of 8.75. Over the past decade, Srivichaivejvivat PCL's EV-to-EBITDA has ranged from 1.97 to 25.77. According to the industry distribution chart, Srivichaivejvivat PCL ranks #73 out of 505 companies in the Healthcare Providers & Services industry, placing it in the top 14.5%.
Is Srivichaivejvivat PCL's EV-to-EBITDA too high?
Srivichaivejvivat PCL's current EV-to-EBITDA of 5.13 is 41% below median its 10-year median of 8.75. Over the past 10 years, this metric has ranged from a low of 1.97 to a high of 25.77. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.98. Srivichaivejvivat PCL's value of 5.13 is 53.3% below this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #73 out of 505 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Srivichaivejvivat PCL has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #73 out of 505 companies for EV-to-EBITDA. This places Srivichaivejvivat PCL in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.98. Srivichaivejvivat PCL's value of 5.13 is 53.3% below this benchmark. Historically, Srivichaivejvivat PCL's own EV-to-EBITDA has ranged from 1.97 to 25.77 over the past decade. While the company's 10-year median is 8.75 vs. the industry median of 10.98, Srivichaivejvivat PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.98, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current EV-to-EBITDA of 5.13 is 53.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Srivichaivejvivat PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current EV-to-EBITDA is 5.13, which is 41% below median its own 10-year median of 8.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current EV-to-EBITDA of 5.13. The stock's GF Value™ is ฿8.92, compared to a current price of ฿8.95 — trading 0.3% above its estimated fair value. The current EV-to-EBITDA is 5.13, which is 41% below median its 10-year median of 8.75 and 53.3% below the Healthcare Providers & Services industry median of 10.98. Srivichaivejvivat PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current EV-to-EBITDA is 5.13 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be overvalued.
The current stock price of ฿8.95 is trading 0.3% above its estimated GF Value™ of ฿8.92.
Key valuation signals for BKK:VIH-R:
EV-to-EBITDA: 5.13 (41% below median its 10-year median of 8.75)
GF Value™: ฿8.92 vs. price of ฿8.95 (0.3% above fair value)
Industry Position: 53.3% below the Healthcare Providers & Services median (#73 of 505)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
81GF Score
Get the complete analysis for BKK:VIH-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
